Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, Bayer’s G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe. G4A Accelerator has two global programs currently running for startups and companies. Join G4A in changing the experience of healthcare today!
The G4A Global Accelerator program 2018 aims to offer mentoring by entrepreneurs and Bayer experts, office space for 100 days, funding of 50,000€, and exclusive networking opportunities for your startup.
Over 100 Bayer experts are involved in the jury process to decide which companies Bayer will work with. Criteria of acceptance into the program include: company maturity, existing product prototypes, the team, as well as the applicant’s fit to Bayer’s areas of expertise and focus areas. The G4A Accelerator 2018 focus areas are: digital therapeutics, blockchain in health care, heart disease prevention, virtual trial solutions, women’s health, AI for R&D, neurological enhancement solutions, as well as physician and patient engagement solutions.
Send your application by May 31st, 2018!
More information about the G4A Global Acceralator program
The G4A Global Dealmaker program 2018 is tailored for mature startups and companies that have a solution ready to go! The new Dealmaker program is all about quality facetime between you and our experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Travel stipends included! In 2018, the focus areas of the G4A Dealmaker program are: established products, women’s health, radiology, ophthalmology, pulmonology, hematology, medical affairs, new product commercialization and oncology.
Send your application by July 8th, 2018!